Holdings
Health Sciences Portfolio
As of Jun 30, 2026, Health Sciences Portfolio reported 126 positions worth US$367M. Largest: Eli Lilly And Company, Johnson & Johnson and Unitedhealth Group Incorporated. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Eli Lilly And Company | 39,510 | US$47.4M | −515 | Jun 30, 2026 |
| Johnson & Johnson | 117K | US$29.6M | −43,015 | Jun 30, 2026 |
| Unitedhealth Group Incorporated | 56,143 | US$23.3M | +15,977 | Jun 30, 2026 |
| Merck & Company, Inc. | 156K | US$20M | −2,099 | Jun 30, 2026 |
| Abbvie Inc. | 76,485 | US$19.2M | +7,603 | Jun 30, 2026 |
| Gilead Sciences, Inc. | 111K | US$14M | +7,846 | Jun 30, 2026 |
| Amgen Inc. | 35,457 | US$12.8M | +287 | Jun 30, 2026 |
| Thermo Fisher Scientific Inc | 22,487 | US$11.3M | +9,657 | Jun 30, 2026 |
| Vertex Pharmaceuticals Incorporated | 21,484 | US$10.7M | no change | Jun 30, 2026 |
| Edwards Lifesciences Corporation | 102K | US$9.26M | no change | Jun 30, 2026 |